TAU targets drug-resistant ovarian tumors with nanotechnology
Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.
Now Prof. Dan Peer of Tel Aviv University‘s Department of Cell Research and Immunology has proposed a new strategy to tackle an aggressive subtype of ovarian cancer using a new nanoscale drug-delivery system designed to target specific cancer cells. He and his team — Keren Cohen and Rafi Emmanuel from Peer’s Laboratory of Nanomedicine and Einat Kisin-Finfer and Doron Shabbat, from TAU’s Department of Chemistry — have devised a cluster of nanoparticles called gagomers, made of fats and coated with a kind of polysugar. When filled with chemotherapy drugs, these clusters accumulate in tumors, producing dramatically therapeutic benefits.
The objective of Peer’s research is two-fold: to provide a specific target for anti-cancer drugs to increase their therapeutic benefits, and to reduce the toxic side effects of anti-cancer therapies. The study was published in February in the journal ACS Nano.
Why chemotherapy fails
According to Prof. Peer, traditional courses of chemotherapy are not an effective line of attack. Chemotherapy’s failing lies in the inability of the medicine to be absorbed and maintained within the tumor cell long enough to destroy it. In most cases, the chemotherapy drug is almost immediately ejected by the cancer cell, severely damaging the healthy organs that surround it, leaving the tumor cell intact.
But with their new therapy, Peer and his colleagues saw a 25-fold increase in tumor-accumulated medication and a dramatic dip in toxic accumulation in healthy organs. Tested on laboratory mice, the gagomer mechanism effects a change in drug-resistant tumor cells. Receptors on tumor cells recognize the sugar that encases the gagomer, allowing the binding gagomer to slowly release tiny particles of chemotherapy into the cancerous cell. As more and more drugs accumulate within the tumor cell, the cancer cells begin to die off within 24-48 hours.
“Tumors become resistant very quickly. Following the first, second, and third courses of chemotherapy, the tumors start pumping drugs out of the cells as a survival mechanism,” said Prof. Peer. “Most patients with tumor cells beyond the ovaries relapse and ultimately die due to the development of drug resistance. We wanted to create a safe drug-delivery system, which wouldn’t harm the body’s immune system or organs.”
The Latest on: Ovarian cancer
[google_news title=”” keyword=”Ovarian cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Ovarian cancer
- Localising BRCA gene mutations to better treat ovarian canceron November 28, 2022 at 1:50 am
An international team highlights the importance of localising BRCA gene mutations for the treatment of ovarian cancer ...
- Dyspareunia 'early indicator' of ovarian cancer - Major difference with early detectionon November 27, 2022 at 7:08 am
Ovarian cancer kills approximately 4,000 women each year in the UK. Here, GP Dr Stephanie Ooi discusses the "early indicators" of the disease.
- Medical Moment: Using PARP inhibitors to stop ovarian canceron November 23, 2022 at 10:23 pm
(WNDU) - Almost 20,000 women developed ovarian cancer this year. 12,000 are expected to die. For years, it’s been known as the silent killer. Symptoms are vague, meaning when it’s caught ...
- After beating ovarian cancer, Chris Evert reflects on what drives her nowon November 23, 2022 at 4:00 pm
When Jeanne went to see a doctor, her stage 4 ovarian cancer diagnosis was devastating—and would change both sisters’ lives forever. In a revealing conversation with CBS Sunday Morning ...
- Southern Illinois University Examining the Use of Cannabis for Ovarian Canceron November 23, 2022 at 11:17 am
Cannabis Science Center are examining how cannabis can be used to treat ovarian cancer. SIU researcher Dr. Dale “Buck” Buchanan, who is also a professor of physiology at the university, is a founding ...
- Can Cannabis Help Cure Ovarian Cancer? New Research At Southern Illinois University Shows Promiseon November 23, 2022 at 6:59 am
Researchers at Southern Illinois University (SIU) may be on the way to determining how cannabis can help cure ovarian cancer, reported the Daily Egyptian, the student-run news organization for the SIU ...
- I've Had Stage 4 Ovarian Cancer For 5 Years. Here's What I Know Now About Living.on November 22, 2022 at 5:42 am
The new images from the mammogram were clean. But the ovarian cancer diagnosed a couple of weeks earlier was, according to my surgeon, “massive.” ER doctors diagnosed my stomach pain as constipation ...
- Ovarian cancer: Early signs of the silent tumour that appear while eatingon November 22, 2022 at 12:18 am
According to experts, there is a particular form of the disease which shows signs only while eating meals – and it is not stomach or liver cancer, the answer is ovarian cancer. What are the ...
- Ovarian Cancer: Tara's Storyon November 18, 2022 at 1:31 am
Tara Mulder was diagnosed with ovarian cancer at age 49, and was referred to Johns Hopkins for treatment. Stone says, “Tara had an ovarian cancer that arises from the surface of the ovary — the most ...
- Racial Disparities Persist in Access to Ovarian Cancer Careon November 16, 2022 at 1:05 pm
Most people with ovarian cancer don’t receive treatments recommended to give them the best possible survival outcomes, and the odds are even lower when patients are Black, a new study finds.
via Bing News